A polycythemia vera JAK2 mutation masquerading as a duodenal cancer mutation

Justin Lee, Jennifer Axilbund, William Dalton, Daniel Laheru, Stanley Watkins, David Chu, Karen Cravero, Berry Button, Kelly Kyker-Snowman, Ian Waters, Christopher Gocke, Josh Lauring, Ben Ho Park

Research output: Contribution to journalArticle

Abstract

Next-generation sequencing (NGS) is increasingly being used in cancer care to identify both somatic tumor driver mutations that can be targeted for therapy, and heritable mutations in the germline associated with increased cancer risk. This report presents a case of a JAK2 V617F mutation falsely identified as a duodenal cancer mutation via NGS. The patient was found to have a history of polycythemia vera, a disorder with a high incidence of JAK2 somatic mutations. Buccal cell DNA showed heterozygosity for the mutation, suggesting that it was potentially germline. However, subsequent resequencing of tumor, adjacent normal tissue, and fingernail DNA confirmed the mutation was somatic, and its presence in tumor and buccal cells resulted from contaminating blood cells. This report highlights important nuances of NGS that can lead to misinterpretation of results with potential clinical implications.

Original languageEnglish (US)
Pages (from-to)1495-1498
Number of pages4
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume14
Issue number12
StatePublished - Dec 1 2016

Fingerprint

Duodenal Neoplasms
Polycythemia Vera
Mutation
Cheek
Neoplasms
Germ-Line Mutation
DNA
Nails
Blood Cells
Incidence

ASJC Scopus subject areas

  • Oncology

Cite this

A polycythemia vera JAK2 mutation masquerading as a duodenal cancer mutation. / Lee, Justin; Axilbund, Jennifer; Dalton, William; Laheru, Daniel; Watkins, Stanley; Chu, David; Cravero, Karen; Button, Berry; Kyker-Snowman, Kelly; Waters, Ian; Gocke, Christopher; Lauring, Josh; Park, Ben Ho.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 14, No. 12, 01.12.2016, p. 1495-1498.

Research output: Contribution to journalArticle

Lee, J, Axilbund, J, Dalton, W, Laheru, D, Watkins, S, Chu, D, Cravero, K, Button, B, Kyker-Snowman, K, Waters, I, Gocke, C, Lauring, J & Park, BH 2016, 'A polycythemia vera JAK2 mutation masquerading as a duodenal cancer mutation', JNCCN Journal of the National Comprehensive Cancer Network, vol. 14, no. 12, pp. 1495-1498.
Lee, Justin ; Axilbund, Jennifer ; Dalton, William ; Laheru, Daniel ; Watkins, Stanley ; Chu, David ; Cravero, Karen ; Button, Berry ; Kyker-Snowman, Kelly ; Waters, Ian ; Gocke, Christopher ; Lauring, Josh ; Park, Ben Ho. / A polycythemia vera JAK2 mutation masquerading as a duodenal cancer mutation. In: JNCCN Journal of the National Comprehensive Cancer Network. 2016 ; Vol. 14, No. 12. pp. 1495-1498.
@article{eecb50f001254b4f93bc5be7cf6f459d,
title = "A polycythemia vera JAK2 mutation masquerading as a duodenal cancer mutation",
abstract = "Next-generation sequencing (NGS) is increasingly being used in cancer care to identify both somatic tumor driver mutations that can be targeted for therapy, and heritable mutations in the germline associated with increased cancer risk. This report presents a case of a JAK2 V617F mutation falsely identified as a duodenal cancer mutation via NGS. The patient was found to have a history of polycythemia vera, a disorder with a high incidence of JAK2 somatic mutations. Buccal cell DNA showed heterozygosity for the mutation, suggesting that it was potentially germline. However, subsequent resequencing of tumor, adjacent normal tissue, and fingernail DNA confirmed the mutation was somatic, and its presence in tumor and buccal cells resulted from contaminating blood cells. This report highlights important nuances of NGS that can lead to misinterpretation of results with potential clinical implications.",
author = "Justin Lee and Jennifer Axilbund and William Dalton and Daniel Laheru and Stanley Watkins and David Chu and Karen Cravero and Berry Button and Kelly Kyker-Snowman and Ian Waters and Christopher Gocke and Josh Lauring and Park, {Ben Ho}",
year = "2016",
month = "12",
day = "1",
language = "English (US)",
volume = "14",
pages = "1495--1498",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "12",

}

TY - JOUR

T1 - A polycythemia vera JAK2 mutation masquerading as a duodenal cancer mutation

AU - Lee, Justin

AU - Axilbund, Jennifer

AU - Dalton, William

AU - Laheru, Daniel

AU - Watkins, Stanley

AU - Chu, David

AU - Cravero, Karen

AU - Button, Berry

AU - Kyker-Snowman, Kelly

AU - Waters, Ian

AU - Gocke, Christopher

AU - Lauring, Josh

AU - Park, Ben Ho

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Next-generation sequencing (NGS) is increasingly being used in cancer care to identify both somatic tumor driver mutations that can be targeted for therapy, and heritable mutations in the germline associated with increased cancer risk. This report presents a case of a JAK2 V617F mutation falsely identified as a duodenal cancer mutation via NGS. The patient was found to have a history of polycythemia vera, a disorder with a high incidence of JAK2 somatic mutations. Buccal cell DNA showed heterozygosity for the mutation, suggesting that it was potentially germline. However, subsequent resequencing of tumor, adjacent normal tissue, and fingernail DNA confirmed the mutation was somatic, and its presence in tumor and buccal cells resulted from contaminating blood cells. This report highlights important nuances of NGS that can lead to misinterpretation of results with potential clinical implications.

AB - Next-generation sequencing (NGS) is increasingly being used in cancer care to identify both somatic tumor driver mutations that can be targeted for therapy, and heritable mutations in the germline associated with increased cancer risk. This report presents a case of a JAK2 V617F mutation falsely identified as a duodenal cancer mutation via NGS. The patient was found to have a history of polycythemia vera, a disorder with a high incidence of JAK2 somatic mutations. Buccal cell DNA showed heterozygosity for the mutation, suggesting that it was potentially germline. However, subsequent resequencing of tumor, adjacent normal tissue, and fingernail DNA confirmed the mutation was somatic, and its presence in tumor and buccal cells resulted from contaminating blood cells. This report highlights important nuances of NGS that can lead to misinterpretation of results with potential clinical implications.

UR - http://www.scopus.com/inward/record.url?scp=85006056573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006056573&partnerID=8YFLogxK

M3 - Article

C2 - 27956534

AN - SCOPUS:85006056573

VL - 14

SP - 1495

EP - 1498

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 12

ER -